We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCE
226
DELISTED
PDC Energy, Inc.
PDCE
| $42.7M | 0.06% |
715,531
-31,816
| -4% | -$1.95M |
|
227
Markel Group
MKL
$25.2B
| $41.3M | 0.06% |
38,036
-2,308
| -6% | -$2.82M |
|
228
US Bancorp
USB
$98.9B
| $40.9M | 0.06% |
1,014,254
-66,891
| -6% | -$3.1M |
|
229
Wintrust Financial
WTFC
$10.7B
| $40.5M | 0.06% |
485,624
+128,122
| +36% | +$10.9M |
|
|
TGNA
230
DELISTED
TEGNA Inc
TGNA
| $40.3M | 0.06% |
1,947,974
-60,117
| -3% | -$1.27M |
|
231
Bankunited
BKU
$3.36B
| $40.1M | 0.06% |
1,168,216
-50,557
| -4% | -$1.89M |
|
232
Synchrony
SYF
$24.5B
| $40M | 0.06% |
1,418,627
-83,748
| -6% | -$2.7M |
|
233
Steven Madden
SHOO
$3.18B
| $39.7M | 0.06% |
1,455,097
+120,133
| +9% | +$3.78M |
|
234
Walker & Dunlop
WD
$1.69B
| $39.5M | 0.06% |
470,048
-13,390
| -3% | -$1.37M |
|
235
Emcor
EME
$33B
| $39.5M | 0.06% |
329,289
+44,810
| +16% | +$5.12M |
|
236
Monster Beverage
MNST
$93.2B
| $39.5M | 0.06% |
907,890
-2,311,854
| -72% | -$107M |
|
|
SNV
237
DELISTED
Synovus
SNV
| $38.9M | 0.06% |
1,033,024
+51,010
| +5% | +$2.02M |
|
238
Kosmos Energy
KOS
$1.45B
| $38.1M | 0.06% |
7,084,076
-4,703
| -0.1% | -$28.5K |
|
239
Nomad Foods
NOMD
$1.67B
| $37.2M | 0.05% |
2,592,791
-217,246
| -8% | -$3.91M |
|
240
Dollar General
DG
$27.2B
| $37M | 0.05% |
154,240
-164,021
| -52% | -$40.5M |
|
241
HDFC Bank
HDB
$119B
| $36.8M | 0.05% |
1,259,440
+330,482
| +36% | +$10.2M |
|
|
PACW
242
DELISTED
PacWest Bancorp
PACW
| $35.8M | 0.05% |
1,564,557
+366,697
| +31% | +$9.87M |
|
243
Assured Guaranty
AGO
$3.78B
| $35.2M | 0.05% |
697,106
-491,313
| -41% | -$26.4M |
|
244
TD Synnex
SNX
$19.6B
| $34.7M | 0.05% |
418,392
-13,245
| -3% | -$1.27M |
|
245
Travel + Leisure Co
TNL
$4.68B
| $34.6M | 0.05% |
1,005,170
+70,405
| +8% | +$2.98M |
|
246
Federal Agricultural Mortgage
AGM
$2.27B
| $33.9M | 0.05% |
333,277
-9,850
| -3% | -$1.04M |
|
247
Phillips 66
PSX
$83.3B
| $33.6M | 0.05% |
416,032
-40,667
| -9% | -$3.47M |
|
248
Evercore
EVR
$13.2B
| $33.5M | 0.05% |
384,128
-7,008
| -2% | -$663K |
|
249
Brink's
BCO
$4.86B
| $33.1M | 0.05% |
657,992
-19,460
| -3% | -$1.08M |
|
250
Cabot Corp
CBT
$4.61B
| $33M | 0.05% |
506,459
-12,133
| -2% | -$855K |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.